Mayne Pharma Inc recalls Liothyronine Sodium Tablets, USP 25 mcg ,100-count bottles, Rx Only, Distributed by Perrigo Minneapolis, MN 55427, NDC…
- Recall date
- November 9, 2017
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0098-2018
- FDA classification
- Class II
- Brand / firm
- Mayne Pharma Inc
- Sold / distributed
- Nationwide within USA
Why it was recalled
Failed Dissolution Specifications.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Liothyronine Sodium Tablets, USP 25 mcg ,100-count bottles, Rx Only, Distributed by Perrigo Minneapolis, MN 55427, NDC 0574-0222-01
Get recall alerts
Free email alert whenever Mayne Pharma Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Mayne Pharma Inc